HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kasem Nithipatikom Selected Research

11,12-epoxy-5,8,14-eicosatrienoic acid

6/2013Roles of endothelial nitric oxide synthase (eNOS) and mitochondrial permeability transition pore (MPTP) in epoxyeicosatrienoic acid (EET)-induced cardioprotection against infarction in intact rat hearts.
6/2010Evidence for a role of opioids in epoxyeicosatrienoic acid-induced cardioprotection in rat hearts.
3/2007Mechanisms by which epoxyeicosatrienoic acids (EETs) elicit cardioprotection in rat hearts.
8/2006Epoxyeicosatrienoic acids in cardioprotection: ischemic versus reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kasem Nithipatikom Research Topics

Disease

18Infarction (Infarctions)
11/2018 - 04/2003
11Ischemia
06/2013 - 04/2003
9Reperfusion Injury
11/2018 - 10/2004
7Myocardial Infarction
11/2018 - 10/2004
7Prostatic Neoplasms (Prostate Cancer)
09/2008 - 01/2002
5Carcinoma (Carcinomatosis)
01/2012 - 09/2007
4Myocardial Ischemia (Ischemic Heart Diseases)
01/2012 - 10/2004
3Neoplasms (Cancer)
08/2008 - 01/2004
2Wounds and Injuries (Trauma)
01/2013 - 12/2011
1Hypoxia (Hypoxemia)
11/2018
1Surgical Wound
12/2011
1Myocardial Stunning (Stunned Myocardium)
06/2010
1Hypertension (High Blood Pressure)
01/2010
1Cardiovascular Diseases (Cardiovascular Disease)
01/2010
1Coronary Occlusion
08/2006
1Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
02/2006
1Prostatic Diseases
02/2006
1Obesity
02/2004
1Breast Neoplasms (Breast Cancer)
01/2004
1Neoplastic Cell Transformation
01/2004

Drug/Important Bio-Agent (IBA)

14AcidsIBA
11/2018 - 10/2004
10Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2013 - 12/2004
9Arachidonic Acid (Vitamin F)IBA
06/2010 - 01/2002
714,15-epoxy-5,8,11-eicosatrienoic acidIBA
11/2018 - 10/2005
5glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA
02/2011 - 12/2004
520-hydroxy-5,8,11,14-eicosatetraenoic acidIBA
01/2007 - 10/2004
411,12-epoxy-5,8,14-eicosatrienoic acidIBA
06/2013 - 08/2006
4Adenosine Triphosphate (ATP)IBA
01/2012 - 12/2004
4EndocannabinoidsIBA
02/2011 - 12/2004
3EnzymesIBA
11/2018 - 01/2007
3KATP ChannelsIBA
02/2012 - 12/2004
3HMR 1098IBA
01/2012 - 12/2004
3cytochrome P-450 omega-hydroxylaseIBA
03/2009 - 12/2004
3AndrogensIBA
09/2007 - 12/2004
3Mixed Function Oxygenases (Monooxygenases)IBA
02/2006 - 10/2004
3DDMSIBA
02/2006 - 10/2004
2Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA
06/2013 - 02/2012
2Barbital (Barbitone)IBA
01/2012 - 06/2008
2Ether (Diethyl Ether)IBA
02/2011 - 01/2010
2Phospholipases (Phospholipase)IBA
01/2007 - 10/2005
2Vasoconstrictor AgentsIBA
01/2007 - 10/2005
2Fatty Acids (Saturated Fatty Acids)IBA
01/2007 - 02/2004
2Miconazole (Monistat)FDA LinkGeneric
12/2004 - 10/2004
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2004 - 01/2002
2ProstaglandinsIBA
01/2004 - 01/2002
2Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA
01/2004 - 01/2002
1EET-BIBA
11/2018
1Prolyl Hydroxylases (Prolyl Hydroxylase)IBA
11/2018
1Cyclosporine (Ciclosporin)FDA LinkGeneric
06/2013
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
06/2013
1Mitochondrial Permeability Transition PoreIBA
06/2013
1Opioid Receptors (Opioid Receptor)IBA
02/2012
1Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA
02/2012
1eribis peptide 94IBA
02/2012
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2012
1Monomeric GTP-Binding ProteinsIBA
01/2012
1Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
01/2012
1Bradykinin Receptors (Bradykinin Receptor)IBA
12/2011
1BradykininIBA
12/2011
1anandamide (arachidonylethanolamide)IBA
02/2011
1noladin etherIBA
02/2011
1Cytochrome P-450 CYP2C8IBA
12/2010
1Messenger RNA (mRNA)IBA
12/2010
1Proteins (Proteins, Gene)FDA Link
12/2010
1Pertussis ToxinIBA
06/2010
1AngiotensinsIBA
01/2010
1EstersIBA
03/2009
1fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
09/2008
1EicosanoidsIBA
08/2008
1Epoxide HydrolasesIBA
06/2008
1Arachidonate 12-Lipoxygenase (12 Lipoxygenase)IBA
09/2007
18,9-epoxyeicosatrienoic acidIBA
03/2007
1Reactive Oxygen Species (Oxygen Radicals)IBA
03/2007
1mitochondrial K(ATP) channelIBA
03/2007
1Vasodilator Agents (Vasodilators)IBA
01/2007
1Hydroxyeicosatetraenoic Acids (HETE)IBA
02/2006
120-hydroxyeicosa-6(Z),15(Z)-dienoic acidIBA
02/2006
1Phospholipases A2 (Phospholipase A2)IBA
10/2005
1Carboxylic Ester HydrolasesIBA
07/2005
1KetonesIBA
07/2005
1CB1 Cannabinoid Receptor (CB1 Receptor)IBA
12/2004
1Cytochrome P-450 CYP4A (Alkane 1 Monooxygenase)IBA
12/2004
117-octadecynoic acidIBA
12/2004
1N- methylsulfonyl- 6- (2- propargyloxyphenyl)hexanamideIBA
12/2004
15-hydroxydecanoic acidIBA
12/2004
1CytochromesIBA
10/2004
1Linoleic Acid (Linoleate)IBA
02/2004
1SteroidsIBA
02/2004
1Indomethacin (Indometacin)FDA LinkGeneric
01/2004
1Prostaglandins EIBA
01/2004
1Celecoxib (Celebrex)FDA Link
01/2004
1G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
01/2004
1baicaleinIBA
04/2003
1phenidoneIBA
04/2003
112-Hydroxy-5,8,10,14-eicosatetraenoic AcidIBA
04/2003

Therapy/Procedure

1Microspheres (Microsphere)
07/2009